|
|
|
|
Vol. 59, Issue 4, 684-691, April 2001
The Cardiac Electrophysiology Laboratories, Departments of
Neurobiology, Pharmacology & Physiology, and Medicine, The University
of Chicago, Chicago, Illinois
Membrane-impermeant quaternary amine local anesthetics QX314 and QX222
can access their binding site on the cytoplasmic side of the
selectivity filter from the outside in native cardiac Na+
channels. Mutation of domain IV S6 Ile-1760 of rat brain IIA Na+ channel or the equivalent (Ile-1575) in the adult rat
skeletal muscle isoform (µ1) creates an artificial access path for
QX. We examined the characteristics of mutation of µ1-I1575 and the resulting QX path. In addition to allowing external QX222 access, I1575A accelerated decay of Na+ current and shifted
steady-state availability by
27 mV. I1575A had negligible effects on
inorganic or organic cation selectivity and block by tetrodotoxin
(TTX), saxitoxin (STX), or µ-conotoxin (µ-CTX). It exposed a site
within the protein that binds membrane-permeant methanethiosulfonate
ethylammonium (MTSEA), but not membrane-impermeant methanethiosulfonate
ethyltrimethylammonium (MTSET) and methanethiosulfonate ethylsulfonate
(MTSES). MTSEA binding abolished the QX path created by this mutation,
without effects on toxin binding. The µ-CTX derivative R13N, which
partially occluded the pore, had no effect on QX access. I1575A exposed
two Cys residues because a disulfide bond was formed under oxidative
conditions, but the exposed Cys residues are not those in domain IV S6,
adjacent to Ile-1575. The Cys mutant I1575C was insensitive to external
Cd2+ and MTS compounds (MTSEA, MTSET, MTSES), and
substitution of Ile with a negatively charged residue (I1575E) did not
affect toxin binding. Ile-1575 seems to be buried in the protein, and its mutation disrupts the protein structure to create the QX path without disturbing the outer vestibule and its selectivity function.
This article has been cited by other articles:
![]() |
I. Bruhova, D. B. Tikhonov, and B. S. Zhorov Access and Binding of Local Anesthetics in the Closed Sodium Channel Mol. Pharmacol., October 1, 2008; 74(4): 1033 - 1045. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Ramos and M. E O'Leary State-dependent trapping of flecainide in the cardiac sodium channel J. Physiol., October 1, 2004; 560(1): 37 - 49. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Sasaki, N. Makita, A. Sunami, H. Sakurada, N. Shirai, H. Yokoi, A. Kimura, N. Tohse, M. Hiraoka, and A. Kitabatake Unexpected Mexiletine Responses of a Mutant Cardiac Na+ Channel Implicate the Selectivity Filter as a Structural Determinant of Antiarrhythmic Drug Access Mol. Pharmacol., August 1, 2004; 66(2): 330 - 336. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. O'Leary, M. Digregorio, and M. Chahine Closing and Inactivation Potentiate the Cocaethylene Inhibition of Cardiac Sodium Channels by Distinct Mechanisms Mol. Pharmacol., December 1, 2003; 64(6): 1575 - 1585. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Khan, L Romantseva, A Lam, G Lipkind, and H A Fozzard Role of outer ring carboxylates of the rat skeletal muscle sodium channel pore in proton block J. Physiol., August 15, 2002; 543(1): 71 - 84. [Abstract] [Full Text] [PDF] |
||||